help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baxter, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baxter, R. C.

Journal of Clinical Endocrinology & Metabolism, Vol 67, 265-272, Copyright © 1988 by Endocrine Society


ARTICLES

Characterization of the acid-labile subunit of the growth hormone- dependent insulin-like growth factor binding protein complex

RC Baxter
Department of Endocrinology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

The insulin-like growth factors (IGFs) circulate predominantly in a 150,000-dalton (150K) complex, the IGF-binding component of which appears to be an acid-stable 53K glycoprotein (BP-53). This study tested the hypothesis that an acid-labile subunit (ALS) reacts with the binding subunit to form the 150K complex. ALS activity was quantitated by the conversion of covalent BP-53-[125I]IGF-I tracer from about 60K to about 150K. DEAE-Sephadex chromatography of serum at pH 8.2 yielded separate peaks of 30-60K BP-53 immunoreactivity and 100-110K ALS which, when mixed, converted the BP-53 to 150K. Whole serum also contained 100- 110K ALS not complexed with BP-53. ALS was markedly acid labile, irreversibly losing activity below pH 4.5. In an assay involving competition between test substances and BP-53-IGF-I tracer in the reaction with partially purified ALS, serum samples, acidified to inactivate endogenous ALS, reacted with potencies proportional to their immunoreactive BP-53 content. Pure BP-53 alone was inactive, but after preincubation with IGF-I or IGF-II, competed with a potency identical to that of BP-53 in acidified serum. Amniotic fluid IGF-binding protein, with or without IGFs, had no activity. These results confirm that serum contains an acid-labile protein which interacts with the acid-stable IGF-binding protein BP-53, when it is occupied by IGFs, to convert it to the 150K form.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Chen, R. Freeman, L. F. Voigt, A. Fitzpatrick, S. R. Plymate, and N. S. Weiss
Prostate Cancer Risk in Relation to Selected Genetic Polymorphisms in Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-3, and Insulin-like Growth Factor-I Receptor
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2461 - 2466.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. Beattie, K. Phillips, J. H Shand, M. Szymanowska, D. J Flint, and G. J Allan
Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis
J. Mol. Endocrinol., February 1, 2005; 34(1): 163 - 175.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. C. Oh, W. Wu, G. Tortolero-Luna, R. Broaddus, D. M. Gershenson, T. W. Burke, R. Schmandt, and K. H. Lu
Increased Plasma Levels of Insulin-Like Growth Factor 2 and Insulin-Like Growth Factor Binding Protein 3 Are Associated with Endometrial Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 748 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. Baxter, S. Meka, and S. M. Firth
Molecular Distribution of IGF Binding Protein-5 in Human Serum
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 271 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. F. Backeljauw and L. E. Underwood
Therapy for 6.5-7.5 Years with Recombinant Insulin-Like Growth Factor I in Children with Growth Hormone Insensitivity Syndrome: A Clinical Research Center Study
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1504 - 1510.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Arosio, S. Garrone, P. Bruzzi, G. Faglia, F. Minuto, and A. Barreca
Diagnostic Value of the Acid-Labile Subunit in Acromegaly: Evaluation in Comparison with Insulin-Like Growth Factor (IGF) I, and IGF-Binding Protein-1, -2, and -3
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1091 - 1098.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Laursen, A. Flyvbjerg, J. O. L. Jørgensen, R. C. Baxter, and J. S. Christiansen
Stimulation of the 150-Kilodalton Insulin-Like Growth Factor-Binding Protein-3 Ternary Complex by Continuous and Pulsatile Patterns of Growth Hormone (GH) Administration in GH-Deficient Patients
J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4310 - 4314.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. P. Rhoads, P. L. Greenwood, A. W. Bell, and Y. R. Boisclair
Organization and Regulation of the Gene Encoding the Sheep Acid-Labile Subunit of the 150-Kilodalton Insulin-Like Growth Factor-Binding Protein Complex
Endocrinology, April 1, 2000; 141(4): 1425 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. M. Janosi, S. M. Firth, J. J. Bond, R. C. Baxter, and P. J. D. Delhanty
N-Linked Glycosylation and Sialylation of the Acid-labile Subunit. ROLE IN COMPLEX FORMATION WITH INSULIN-LIKE GROWTH FACTOR (IGF)-BINDING PROTEIN-3 AND THE IGFs
J. Biol. Chem., February 26, 1999; 274(9): 5292 - 5298.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Juul, S. Møller, E. Mosfeldt-Laursen, M. H. Rasmussen, T. Scheike, S. A. Pedersen, K. W. Kastrup, H. Yu, J. Mistry, S. Rasmussen, et al.
The Acid-Labile Subunit of Human Ternary Insulin-Like Growth Factor Binding Protein Complex in Serum: Hepatosplanchnic Release, Diurnal Variation, Circulating Concentrations in Healthy Subjects, and Diagnostic Use in Patients with Growth Hormone Deficiency
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4408 - 4415.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. M. Twigg, M. C. Kiefer, J. Zapf, and R. C. Baxter
Insulin-like Growth Factor-binding Protein 5 Complexes with the Acid-labile Subunit. ROLE OF THE CARBOXYL-TERMINAL DOMAIN
J. Biol. Chem., October 30, 1998; 273(44): 28791 - 28798.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. F. Collett-Solberg, S. E. Nunn, T. B. Gibson, and P. Cohen
Identification of Novel High Molecular Weight Insulin-Like Growth Factor-Binding Protein-3 Association Proteins in Human Serum
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2843 - 2848.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Skjærbæk, J. Frystyk, H. Ørskov, P. Kissmeyer-Nielsen, M. B. Jensen, S. Laurberg, N. Møller, and A. Flyvbjerg
Differential Changes in Free and Total Insulin-Like Growth Factor I after Major, Elective Abdominal Surgery: The Possible Role of Insulin-Like Growth Factor-Binding Protein-3 Proteolysis
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2445 - 2449.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Sandra, M. Boes, B. L. Dake, J. B. Stokes, and R. S. Bar
Infused IGF-I/IGFBP-3 complex causes glomerular localization of IGF-I in the rat kidney
Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E32 - E37.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. M. Shalet, A. Toogood, A. Rahim, and B. M. D. Brennan
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Endocr. Rev., April 1, 1998; 19(2): 203 - 223.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. M. Twigg and R. C. Baxter
Insulin-like Growth Factor (IGF)-binding Protein 5 Forms an Alternative Ternary Complex with IGFs and the Acid-labile Subunit
J. Biol. Chem., March 13, 1998; 273(11): 6074 - 6079.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. Rajaram, D. J. Baylink, and S. Mohan
Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions
Endocr. Rev., December 1, 1997; 18(6): 801 - 831.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. C. Baxter
The Binding Protein's Binding Protein-- Clinical Applications of Acid-Labile Subunit (ALS) Measurement
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3941 - 3943.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. J. Khosravi, A. Diamandi, J. Mistry, R. G. Krishna, and A. Khare
Acid-Labile Subunit of Human Insulin-Like Growth Factor-Binding Protein Complex: Measurement, Molecular, and Clinical Evaluation
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3944 - 3951.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
G. T. Ooi, F. J. Cohen, L. Y.-H. Tseng, M. M. Rechler, and Y. R. Boisclair
Growth Hormone Stimulates Transcription of the Gene Encoding the Acid-Labile Subunit (ALS) of the Circulating Insulin-Like Growth Factor-Binding Protein Complex and ALS Promoter Activity in Rat Liver
Mol. Endocrinol., June 1, 1997; 11(7): 997 - 1007.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Y. Lee, H.-B. Wu, D.-S. Suh, and M. M. Rechler
Insulin-Like Growth Factor-I (IGF-I) Concentration in 150-Kilodalton Complexes Containing Human IGF-Binding Protein-3 (hIGFBP-3) after Intravenous Injection of Adult Rats with hIGFBP-3
Endocrinology, April 1, 1997; 138(4): 1649 - 1657.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society